Amyloid Antibodies as Future Treatment for Early Alzheimer’s Disease?
More antibodies targeting amyloid have been developed, and one of the raising questions is if they are usable in treating Alzheimer’s disease. In this MEDtalk, Consultant Neurologist Kristian Steen Frederiksen presents studies investigating the efficacy and safety of the drug lecanemab.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
